The move to self-administration with a syringe and needle, just like how insulin is often taken for diabetes, means a whole ...

Novo Nordisk and Eli Lilly are offering discounts to encourage more insurance coverage of the medicines, which carry price ...

The lowest dose of Novo's Wegovy used to start new patients remains listed as in shortage. Patrik Jonsson, Lilly's president of cardiometabolic health, said in an interview that the vials launch ...

Zepbound and Wegovy are currently listed as available, but still in shortage, according to the FDA. The smaller vials will help boost Lilly’s supply and help the company meet high demand as ...

The lowest dose of Novo's Wegovy - which is used to start new patients ... said the launch of these vials will significantly increase supplies of Zepbound in the U.S. "We are very confident ...

Single-dose vials containing 2.5 and 5 mg of tirzepatide ... Ozempic to be prescribed for weight loss under the brand name Wegovy — giving way to a massive new wave of chronic weight management.

In July, the U.S. Food and Drug Administration warned that people are overdosing on compounded semaglutide injectable ...

The new 2.5 milligram (mg) and 5 mg weekly dose vials differ from the standard preloaded injector pens that are used to administer Zepbound (tirzepatide) and competitors such as Wegovy (semaglutide).

The company shipped some 750 vials of testosterone to customers who had instead ordered ... struggled to meet demand after ...

Wegovy and Zepbound have gone in and out of ... the additional volume from vials “could prove to be a positive offset” to Lilly’s sales, analysts from Morgan Stanley said in a note.

The new 2.5 milligram (mg) and 5 mg weekly dose vials differ from the standard preloaded injector pens that are used to administer Zepbound (tirzepatide) and competitors such as Wegovy (semaglutide).